⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
ALDX News
Aldeyra Therapeutics, Inc.
ROSEN, A TRUSTED AND LEADING LAW FIRM, Encourages Aldeyra Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm - ALDX
globenewswire.com
ALDX
Pomerantz LLP Advises Shareholders of Class Action Involving Aldeyra Therapeutics, Inc. – ALDX
accessnewswire.com
ALDX
Bronstein, Gewirtz & Grossman LLC Urges Aldeyra Therapeutics, Inc. Investors to Act: Class Action Filed Alleging Investor Harm
globenewswire.com
ALDX
Pomerantz LLP Advises of Securities Class Action Involving Aldeyra Therapeutics, Inc. – ALDX
accessnewswire.com
ALDX
Bronstein, Gewirtz & Grossman, LLC Encourages Aldeyra Therapeutics, Inc. (ALDX) Shareholders to Inquire about Securities Investigation
accessnewswire.com
ALDX
ALDX SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Reminds Aldeyra Therapeutics (ALDX) Investors of Securities Class Action Deadline on May 29, 2026 Ready to Announce with Confidence?
newsfilecorp.com
ALDX
ALDX INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Aldeyra Therapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!
accessnewswire.com
ALDX
Pomerantz LLP Advises Shareholders of Class Action Filing Involving Aldeyra Therapeutics, Inc. – ALDX
accessnewswire.com
ALDX
Pomerantz LLP Advises of Securities Class Action Against Aldeyra Therapeutics, Inc. – ALDX
accessnewswire.com
ALDX
ROSEN, SKILLED INVESTOR COUNSEL, Encourages Aldeyra Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm - ALDX
accessnewswire.com
ALDX